Diabetes Mellitus

Diabetes Mellitus Glycemic Crisis and Care

Key Points

• Diabetes mellitus is chronic hyperglycemia caused by absent insulin, insulin resistance, or both.
• Type 1 diabetes reflects autoimmune beta-cell destruction, while Type 2 diabetes is driven by insulin resistance and relative insulin deficiency.
• Hypoglycemia is blood glucose below 70 mg/dL and requires rapid treatment with carbohydrate and reassessment.
• Severe hyperglycemia can progress to diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) with life-threatening instability.
• Core nursing priorities are glucose control, complication prevention, and sustained self-management education.

Pathophysiology

Diabetes mellitus (DM) is a chronic disorder of glucose regulation in which blood glucose remains persistently elevated. Dysfunction of pancreatic islet-cell hormone balance prevents normal insulin-glucagon control and leads to sustained hyperglycemia.

In Type 1 DM, autoimmune injury destroys beta islet cells, producing an absolute insulin deficiency. In Type 2 DM, peripheral tissues become resistant to insulin and pancreatic insulin production becomes insufficient over time. Gestational diabetes occurs during pregnancy and increases later Type 2 DM risk. Latent autoimmune diabetes in adults (LADA) progresses more gradually than classic Type 1 DM.

Classification

• Type 1 DM: Autoimmune beta-cell destruction with little or no endogenous insulin.
• Type 2 DM: Insulin resistance with progressive beta-cell dysfunction.
• Gestational DM: Pregnancy-associated dysglycemia with future Type 2 DM risk.
• LADA: Slowly progressive autoimmune diabetes beginning in adulthood.

Nursing Assessment

NCLEX Focus

Prioritize early recognition of hypo- versus hyperglycemia, then escalate quickly for neurologic, hemodynamic, or respiratory deterioration.

• Assess classic hyperglycemia-related manifestations, including polyuria, polydipsia, polyphagia, fatigue, and delayed healing.
• Monitor for hypoglycemia symptoms (confusion, tremor, diaphoresis, tachycardia, anxiety, dizziness, blurred vision), especially in insulin-treated clients.
• Monitor for severe hyperglycemia and crisis cues, including dehydration, altered mentation, hypotension, and potential acidosis signs.
• Monitor skin/wound status because sustained hyperglycemia can worsen perfusion and leukocyte function, delaying wound healing.
• Monitor for severe hyperglycemia cues highlighted at bedside (for example fruity breath odor, warm dry skin, deep rapid breathing) and escalate immediately.
• Distinguish hypoglycemia severity bands: mild below 70 mg/dL, moderate below 40 mg/dL, and severe below 20 mg/dL with inability to swallow, seizure risk, or unconsciousness.
• Track diagnostic values: fasting glucose 70-100 mg/dL normal; fasting glucose 126 mg/dL or higher on two tests supports DM diagnosis.
• Review HbA1c trends: less than 5.7% normal, 5.7%-6.4% prediabetes, and 6.5% or higher diagnostic for DM.
• Use adjunct diagnostics to clarify phenotype and crisis risk: fasting C-peptide about 0.5-2.0 ng/mL, urine ketone checks when glucose exceeds 240 mg/dL, and urine glucose spillover when serum glucose rises above about 160-180 mg/dL.
• Assess Type 2 DM risk profile for early prevention counseling: prediabetes, overweight/obesity, sedentary pattern, age 45 or older, family history, prior gestational diabetes or macrosomic infant history, and high-risk ethnicity patterns.

Nursing Interventions

• Implement rapid hypoglycemia response using the 15-15 strategy: give 15 g carbohydrate, recheck glucose in 15 minutes, and repeat until at least 70 mg/dL.
• Follow agency protocol for moderate or severe hypoglycemia, including escalation to glucagon or IV dextrose when swallowing is unsafe; severe episodes may require repeat rescue dosing and ED transfer if consciousness does not recover.
• Reinforce medication adherence for insulin and non-insulin regimens and align timing with meal intake and activity.
• Teach blood glucose monitoring patterns and when to assess ketones, including monitoring when glucose exceeds 240 mg/dL.
• Provide structured nutrition teaching: distribute carbohydrates evenly, use lower glycemic-index choices, target protein about 15%-20% of calories, limit saturated fat to less than 7%, and increase fiber intake to at least 25 g daily.
• When prescribed, reinforce a consistent-carbohydrate meal pattern (similar carbohydrate amount each meal) to reduce hypo/hyperglycemic swings.
• Start diabetes nutrition teaching with a learner assessment (current knowledge, prior experience, readiness, literacy level, preferred learning mode, and cultural/religious food influences) to individualize education.
• Adapt teaching for language and health-literacy needs using qualified medical interpreters, plain-language tools, and teach-back with culturally relevant food examples.
• Teach practical carbohydrate counting for mealtime insulin dosing (15 g carbohydrate equals one carbohydrate choice) and verify understanding with worked meal examples.
• Differentiate carbohydrate-planning methods during teaching: advanced carb counting for intensive insulin regimens (multiple daily injections or pump therapy) versus simpler carbohydrate-choice plans when prescribed.
• Teach the diabetes plate method when appropriate: half non-starchy vegetables, one quarter lean protein, and one quarter carbohydrate foods.
• Include practical diet-self-management topics such as carbohydrate awareness, portion control, personalized meal planning, sugar-substitute selection to reduce added sugars, and label reading focused on carbohydrate/fiber/sugar lines.
• Reinforce use of reliable nutrition references/apps (for example USDA FoodData Central) so clients can estimate carbohydrate grams more accurately.
• Coach exercise planning to reduce glycemic variability: avoid long inactivity gaps, monitor glucose before/during/after activity, and keep fast-acting carbohydrate available to prevent exercise-related hypoglycemia.
• Build affordability-focused self-management plans: low-cost nutrition options, no-cost activity plans, and feasible glucose-monitoring strategies matched to financial constraints.
• Reinforce foot and skin protection and preventive follow-up, including annual eye and podiatry exams, kidney surveillance with microalbumin, blood pressure checks, and lipid monitoring.
• Reinforce early reporting of skin injury in patients with neuropathy because reduced pain sensation can delay treatment and increase infection risk.
• In neuropathy-focused foot care, inspect plantar surfaces and between toes daily, ensure well-fitted footwear and non-irritating sock seams, and report skin breaks early; avoid NA nail trimming in high-risk diabetic feet per facility policy.
• Teach sick-day action planning: check glucose at least every 4 hours, maintain hydration, test urine ketones every 4-6 hours when indicated, and escalate for persistent vomiting/diarrhea or fever.
• Connect patients and families (with consent) to community supports such as medication-assistance programs, sliding-scale clinics, food resources, and telehealth-friendly follow-up when transportation or work schedules limit access.

Glycemic Emergency Progression

Uncontrolled glucose abnormalities can rapidly progress to seizure, coma, arrhythmia, shock, or death without prompt treatment and escalation.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
insulin	class-based insulin regimens	Match dosing with meals/activity and monitor for hypoglycemia.
biguanides	metformin	Used in Type 2 DM; monitor response and reinforce adherence.
sulfonylureas	glipizide, glyburide, glimepiride	Stimulate insulin release; monitor for low-glucose episodes.
DPP-4 inhibitors	sitagliptin, saxagliptin	Support glucose control; monitor effectiveness with trend data.
GLP-1 receptor agonists	class-based injectables	Improve glycemic control and satiety; reinforce administration steps.

Clinical Judgment Application

Clinical Scenario

A client with Type 2 DM has increasing thirst, frequent urination, fatigue, and random glucose values repeatedly above goal after recent illness and poor intake.

• Recognize Cues: Persistent hyperglycemia symptoms with dehydration risk.
• Analyze Cues: Current regimen and self-management are insufficient during acute stress.
• Prioritize Hypotheses: Highest priority is preventing progression to hyperglycemic crisis.
• Generate Solutions: Intensify monitoring, implement provider-ordered medication adjustment, and reinforce sick-day guidance.
• Take Action: Reassess glucose trends, hydration status, and mental status; escalate concerning findings promptly.
• Evaluate Outcomes: Glucose trends improve, hydration stabilizes, and no DKA/HHS transition occurs.

Related Concepts

• metabolic-syndrome-and-adult-chronic-disease-risk - Shared risk-pattern context for Type 2 diabetes progression.
• hypertension-assessment-and-management - Common comorbidity that accelerates vascular injury in DM.
• peritoneal-and-hemodialysis-nursing-management - Relevant when diabetic nephropathy progresses to kidney failure.
• Hyperosmolar hyperglycemic state (HHS) - Severe Type 2 hyperglycemic emergency with profound dehydration risk.
• Diabetic ketoacidosis (DKA) - High-risk metabolic emergency associated with insulin deficiency and acidosis.

Self-Check

1. Which glucose and HbA1c thresholds distinguish normal, prediabetes, and diabetes ranges?
2. How does the 15-15 hypoglycemia approach reduce immediate neurologic risk?
3. Which assessment findings should prompt concern for progression to DKA or HHS?